Loading...

SHALBY Shalby Ltd Investor Conferences Announcement

Shlb

SHLB

Shalby Ltd

(SHALBY)

2025 Announcement

Show Summary

Show Summary

Credit Rating Update

Earnings Call Transcript

Earnings Call Audio

Financial Results Published

Q4 FY25 Results

Appointment of Auditors

Earnings Call Scheduled

Compliance Report

Compliance Certificate

Promoter Disclosure

Equity Shares Allotment

Franchise Termination

Credit Rating Update

Hand Transplant Approval

Postal Ballot Notice

Earnings Conference Call

GST Penalty Notice

Earnings Call Update

Investor Presentation

Financial Results Publication

Q3 FY25 Results

Management Change

Earnings Call Scheduled

Investor Meeting

Tissue & Bone Bank

Compliance Certificate

Employee Stock Options

Share Acquisition

Insider Purchase Report

Earnings Call Transcript

Financial Results Announcement

Investor Conference

Q2 FY25 Performance

Q2 FY2025 Results

Earnings Conference Call

Management Change

Regulatory Compliance

International Accreditation

Award Recognition

Bone Bank License

AGM Announcement

AGM Notice Published

Management Change

Clinical Trial Agreement

Appointment Announcement

Grant of Stock Options

Term Loan Availment

Stock Options Exercise

Shalby Ltd Expansion

Stock Options Exercise

Stock Options Grant

Investor Conference Call Ou...

Financial Results Publication

Financial Results Announcement

Investor Presentation

Management Change

Investor Conference Call

Certificate Received

Investor Conference Call

Franchise Agreement Termina...

Financial Facilities Approval

Acquisition of Shares

Insider Trading Disclosure

Exercise of Employee Stock ...

Stock options exercised

Investor Conference Audio R...

Publication Submission

Financial Results

Financial Results & Acquisi...

Financial Disclosure

Corporate Guarantee Issued

Investor Conference Call

Allotment of Shares

Employee Stock Option Exercise

Compliance Report Submission

Corporate Guarantee Issued

Subsidiary Incorporation

Working Capital Facilities ...

Certificate Submission

Shareholding Disclosure

Compliance Certification

Certificate Submission

Acquisition Update

Term Loan Acquisition

Investment Acquisition

Acquisition Announcement

Acquisition of Shares

Equity Purchase Disclosure

Audio Call Recording

Investor Presentation

Submission of Newspaper pub...

Financial Results

Stock Options Grant

Investor Conference Call

Resignation of Chief Busine...

Closure of Corporate Guarantee

Acquisition in PK Healthcar...

Stock Options Exercise

Acquisition of Stake

MOU with Kaushalya, The Ski...

Appointment of Senior Manag...

Certificate Submission

Investment Approval

Working Capital Facilities

Investor Meeting

Stock Options Exercise

Investor Meeting

Investor Meeting

Change in Senior Management

Amendment Agreement for New...

Conference Call

Financial Results

Investor Presentation

Financial Results

Award Announcement

Investor Conference Call

Litigation Update

Meeting with Investor/Analyst

Certificate Submission

ODR Portal Registration

Investment Approval

Preference Shares Allotment

Investor Meeting

Investor Meeting

Civil litigation

Geographic Expansion

Investor Meetings

Financial Results - Unaudited

AGM and Book Closure

Conference Call - Financial...

Financial Statements

Financial Statements

Investor Meetings

Equity Offerings

Partnerships and Collaborat...

Investor Meetings

Geographic Expansion

Volume behavior clarification

Management Changes

Financial Statements

Financial Statements

Management Changes

Financial Results

Publication of results

Related Party Transactions

Financial Operations

Financial Statements

CFO Resignation and Appoint...

Management Changes

External Links:

Data:

Shalby Ltd will present its financial performance for Q3 FY25, with consolidated revenue of 2,811 million compared to 2,206 million in Q3 FY24, during an Investor Conference call on February 5, 2025.

AI Assistant

Shalby Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.